Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions

被引:56
作者
Barbaud, A
Trechot, P
Reichert-Penetrat, S
Commun, N
Schmutz, JL
机构
[1] Hop Fournier, Dermatol Serv, Dept Dermatol, F-54000 Nancy, France
[2] Fournier Hosp, Pharm Lab, F-54000 Nancy, France
[3] Fournier Hosp, Dept Pharmacol, F-54000 Nancy, France
关键词
cutaneous adverse drug reaction; skin tests with drugs; intradermal testing; patch tests with drugs; relevance scoring system; colchicine; misoprostol; antibiotics; betalactam antibiotics; non-steroidal anti-inflammatory drugs;
D O I
10.1034/j.1600-0536.2001.450502.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Skin tests with drugs can be of value in investigating patients who have developed cutaneous adverse drug reactions (CADR), but their specificity and relevance remain to be determined. A false-positive result on skin testing can happen if it is not compared to results in control subjects. When performing intradermal tests (IDT), we have determined the lowest concentrations that induce false-positive results for many drugs, including betalactam antibiotics, cephalosporins, other antibiotics or non-steroidal anti-inflammatory drugs. Some drugs in their commercialized form contain sodium lauryl sulfate and can induce irritation when patch tested as such. When patch tested with colchicine at 10% in pet. or with a Cytotec((R)) pill (containing misoprostol) at 30% in pet., respectively, 80% of the 29 and 9 of the 10 negative controls developed false-positive results. Lastly, positive results of patch tests with drugs can be related to contact allergy to one of the components of the commercialized form of the drug, without any relevance to the investigation of a CADR, as observed in 2 cases with iodine or avocado oil.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 6 条
[1]  
Barbaud A, 1998, BRIT J DERMATOL, V139, P49
[2]  
Barbaud A, 2000, B ACAD NAT MED PARIS, V184, P47
[3]  
CALKIN JM, 1993, CONTACT DERMATITIS, V29, P223
[4]   A proposed relevance scoring system for positive allergic patch test reactions: Practical implications and limitations [J].
Lachapelle, JM .
CONTACT DERMATITIS, 1997, 36 (01) :39-43
[5]  
MOORE N, 1985, LANCET, V2, P1056
[6]  
OSAWA J, 1990, Journal of Dermatology (Tokyo), V17, P235